- Report
- August 2025
- 188 Pages
Global
From €3483EUR$3,939USD£3,007GBP
- Report
- April 2025
- 200 Pages
Global
From €3970EUR$4,490USD£3,427GBP
- Report
- August 2025
- 271 Pages
Global
From €5172EUR$5,850USD£4,465GBP
- Report
- June 2025
- 400 Pages
Global
From €4376EUR$4,949USD£3,778GBP
- Report
- January 2025
- 250 Pages
Global
From €4420EUR$4,999USD£3,816GBP
- Report
- June 2025
Global
From €6631EUR$7,500USD£5,725GBP
- Report
- August 2025
- 105 Pages
Global
From €2343EUR$2,650USD£2,023GBP
- Report
- August 2025
- 196 Pages
Global
From €3483EUR$3,939USD£3,007GBP
- Report
- August 2025
- 182 Pages
Global
From €3134EUR$3,545USD£2,706GBP
€3483EUR$3,939USD£3,007GBP
- Report
- August 2025
- 195 Pages
Global
From €3483EUR$3,939USD£3,007GBP
- Report
- January 2025
- 175 Pages
Global
From €3970EUR$4,490USD£3,427GBP
- Report
- January 2025
- 175 Pages
Global
From €3970EUR$4,490USD£3,427GBP
- Report
- August 2025
- 182 Pages
Global
From €5172EUR$5,850USD£4,465GBP
- Report
- August 2025
- 481 Pages
Global
From €5172EUR$5,850USD£4,465GBP
- Report
- August 2025
- 377 Pages
Global
From €5172EUR$5,850USD£4,465GBP
- Report
- April 2025
- 175 Pages
Global
From €3970EUR$4,490USD£3,427GBP
- Report
- February 2025
- 200 Pages
Global
From €3970EUR$4,490USD£3,427GBP
- Report
- August 2025
- 374 Pages
Global
From €5172EUR$5,850USD£4,465GBP
- Report
- August 2025
- 202 Pages
Global
From €5172EUR$5,850USD£4,465GBP
- Report
- May 2023
- 169 Pages
Global
From €2078EUR$2,350USD£1,794GBP

The HIV market within the context of Allergy and Immunology is focused on the development of treatments and therapies for HIV/AIDS. This includes the development of drugs, vaccines, and other treatments to prevent and manage the virus. Research is also conducted to understand the underlying mechanisms of HIV and its effects on the immune system. Additionally, the market includes the development of diagnostics and tests to detect the virus and monitor its progression.
The HIV market is highly competitive, with many companies involved in the development of treatments and therapies. These include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and ViiV Healthcare. Other companies involved in the market include AbbVie, Janssen, and Pfizer. Show Less Read more